About this trial
Patients with large, complex, or giant incisional hernias often require advanced preoperative optimization to facilitate safe abdominal wall reconstruction and reduce postoperative complications. Several strategies are currently used in clinical practice, including botulinum toxin A injection, progressive preoperative pneumoperitoneum, and their combination. However, the optimal differentiated approach based on hernia characteristics and abdominal wall tissue deficiency remains unclear.
This study aims to compare the effectiveness and safety of different preoperative preparation strategies in patients with large postoperative ventral hernias and loss of abdominal wall domain. Outcomes of patients receiving botulinum toxin A, progressive preoperative pneumoperitoneum, combined preparation, or no specific preparation will be analyzed.
The study will evaluate operative feasibility, ability to achieve fascial closure, postoperative complications, recurrence, and overall treatment outcomes.
Eligibility criteria
Qualifiers
Adults aged 18 years or older
Patients with ventral incisional hernia requiring elective surgical repair
Large and/or complex hernia defects requiring preoperative preparation
Ability to provide informed consent
Disqualifiers
Age under 18 years
Emergency surgery
Pregnancy
Contraindications to botulinum toxin A injection or progressive pneumoperitoneum
Trial design
Treatments tested in this trial
- Botulinum Toxin A (Botox )
- Progressive Preoperative Pneumoperitoneum
- Combined Preoperative Preparation
- Standard Preoperative Management